Advertisement.
Advertisement.
Advertisement
Advertisement.
ETON Eton Pharmaceuticals Inc
5,580
| Market Cap | $91.72M |
| Volume | 18,513.00 |
| 52-Wk High | $5.81 |
| 52-Wk Low | $2.42 |
Craig-Hallum Sticks to Its Buy Rating for Eton Pharmaceuticals (ETON)
TipRanks Financial Blog•10 days ago
In a report released today, Chase Knickerbocker from Craig-Hallum maintained a Buy rating on Eton Pharmaceuticals (ETON Research Report). The com...
Share to Feed
This is a signal that ETON's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Technical Analysis•4 months ago
This is a signal that ETON's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...
Tickeron - Stocks•4 months ago
Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE...
Seeking Alpha - Healthcare•4 months ago
GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering...
Accesswire•4 months ago
PKU GOLIKE is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024...
Globe Newswire•4 months ago
This indicator may be signaling that ETON's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Tickeron - Stocks•4 months ago
Related Stocks: NAS:ETON...
GuruFocus•4 months ago
Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript...
SeekingAlpha•4 months ago
ETON Sees Over 100% Year-Over-Year Increase in Q4 Product Sales; Prepares for New Drug ApplicationsRelated Stocks: ETON...
GuruFocus•4 months ago